Beating 96% of peers, this fund has a bullish stance on hospital stocks
Get link
Facebook
X
Pinterest
Email
Other Apps
[hfe_template id='11223']
[ad_1]
India’s hospital stocks are set to benefit from the expected growth in healthcare spending, according to one of the country’s top-performing funds.
The country will witness a rapid acceleration in the number of people reaching retirement age in the next two decades, Satish Ramanathan, chief investment officer for equities at JM Financial Asset Management Ltd., said in an interview. “People will spend on healthcare at an unprecedented rate.”
Prime Minister Narendra Modi’s government recently approved expanding a free health-insurance plan for all citizens aged 70 and above. The plan may prompt some regional governments to introduce similar measures, providing a boost to the sector, according to Ramanathan, who oversees more than $1 billion.
Bloomberg
Some of the biggest players in the industry — Max Healthcare Institute Ltd. and Apollo Hospitals Enterprise Ltd. have gained 43% and 26%, respectively, in 2024. The momentum will likely continue as a widening insurance coverage provides hospitals another impetus to expand in a country that has just 1.3 hospital beds per 1,000 people.“Currently India doesn’t have a safety net,” said Ramanathan. However, the government is becoming more cognizant of the situation and taking measures to tackle it, he added.
JM Flexicap Fund has returned over 40% this year, beating over 96% of peers during the period, according to data compiled by Bloomberg. It has been the best performer in its category over a three-year time frame, the data show.
Shares of ICICI Bank Ltd. and REC Ltd. — which are among the top-10 holdings — have gained 28% and 34%, respectively, in 2024. In comparison, the NSE Nifty 50 Index has gained about 19%.
The fund held shares of Global Health Ltd., the operator of Medanta Hospitals, according to its most recent filing. The asset manager’s mid-cap fund held Fortis Healthcare Ltd. as of Aug. 31.
[hfe_template id='11223']
[ad_1]
Volatility in Indian equity markets has surged sharply over the past month, with the India VIX nearly doubling as geopolitical tensions and global uncertainty triggered aggressive selling in equities. India VIX, often referred to as the market’s fear gauge, has jumped close to 100% over the past month, reflecting growing nervousness among investors. The spike has coincided with a sharp correction in the broader market, with the Nifty 50 declining about 8% during the same period. The escalation of tensions involving the United States, Israel and Iran has intensified market anxiety in recent days, pushing crude oil prices sharply higher and triggering a global risk-off sentiment. However, analysts note that volatility had already been building even before the conflict escalated, reflecting broader concerns around global growth, foreign capital outflows and stretched valuations in equities. The heightened uncertainty translated into a sharp ...
[hfe_template id='11223']
[ad_1]
Benchmark indices Sensex and Nifty ended the week on a bearish note, closing over a percent lower each as a deepening selloff in IT stocks rattled investor sentiment amid mounting fears of AI-led disruption. Further, stronger-than-expected jobs data for January dampened hopes of a US Fed interest rate cut. Here are 7 factors that could decide market action in the coming week: 1.) Infosys, Wipro ADRs rebound - After a brutal two-day selloff that saw Infosys and Wipro ADRs plunge as much as 14.5%, Friday’s session brought a much-needed breather. Bargain hunting kicked in at lower levels, sparking a sharp rebound as Infosys climbed 3% while Wipro gained 4%—helping both stocks close the week on a far stronger note. International brokerage firm JP Morgan has a message for panic-stricken investors: IT services firms are the indispensable "plumbers of the tech world" and their dividend yields have now hit levels last seen only during ...
[hfe_template id='11223']
[ad_1]
Waaree Energies shares will be in focus on Wednesday after the solar panel maker reported a strong Q4 performance, with net profit rising 34.1% year-on-year (YoY) to Rs 618.9 crore for the quarter ended March 31, 2025. In the same quarter last year, the company had reported a profit of Rs 461.5 crore. Revenue from operations jumped 36.4% to Rs 4,003.9 crore, up from Rs 2,935.8 crore in the year-ago period, according to the company’s regulatory filing. EBITDA more than doubled to Rs 922.6 crore in Q4 FY25, up 120.6% from Rs 418.3 crore in the same quarter last year. The EBITDA margin improved to 23% from 14.3% a year ago. The company produced 2.06 GW of solar modules in the fourth quarter, up from 1.35 GW in the same period last year. For the full year, module production reached 7.13 GW, compared to 4.77 GW in FY24. For the full financial year FY25, revenue rose 27.62% YoY to Rs 14,846.06 crore. Profit after tax more than doubled to Rs 1,9...
[hfe_template id='11223']
[ad_1]
Bloomberg
Comments
Post a Comment